Horizon Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Horizon Financial Services’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.8K	Buy	72 +29	+67%	+$12.9K	0.01%	189
2026 Q1	$19.2K	Buy	43 +26	+153%	+$12.1K	0.01%	189
2025 Q4	$7.71K	Buy	17 +4	+31%	+$1.72K	﹤0.01%	218
2025 Q3	$5.09K	Buy	13 +11	+550%	+$4.6K	﹤0.01%	280
2025 Q2	$890	Hold	2	–	–	﹤0.01%	268
2025 Q1	$970	Sell	2 -4	-67%	-$1.86K	﹤0.01%	228
2024 Q4	$2.42K	Hold	6	–	–	﹤0.01%	164
2024 Q3	$2.79K	Hold	6	–	–	﹤0.01%	162
2024 Q2	$2.81K	Hold	6	–	–	﹤0.01%	158
2024 Q1	$2.51K	Buy	+6	New	+$2.54K	﹤0.01%	172

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

CTB

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

GIA

Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Horizon Financial Services's VRTX Position: Q2 2026 in Review

Horizon Financial Services increased its Vertex Pharmaceuticals (VRTX) stake by 67% in Q2 2026, buying an estimated $12.9K and bringing the position to 72 shares worth $35.8K. The position accounts for 0.01% of the portfolio, ranked #189.

Horizon Financial Services first reported a position in VRTX in Q1 2024 and has held it in 10 quarters since. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Horizon Financial Services held 72 shares of Vertex Pharmaceuticals worth $35.8K as of Q2 2026.
Horizon Financial Services bought 29 Vertex Pharmaceuticals shares in Q2 2026, an estimated $12.9K.
Vertex Pharmaceuticals made up 0.01% of Horizon Financial Services's portfolio in Q2 2026, its #189 holding.
Horizon Financial Services first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Horizon Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.